4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001714899-25-000002
Director sold 30,000 shares at $20.25 ($607,500)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Krognes Steve E. Director | 2024-12-31 | Sale 10b5-1 | −30,000 | $20.25 | $607,500 | 29,096 | D |
| Open-market sales · 30,000 sh · avg $20.25 · $607,500 | |||||||
Loading xslF345X05/wk-form4_1735938858.xml…